Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study ProtocolBenjamin Levy, Jonathan W. Riess, Delvys Rodríguez‐Abreu et al.|Clinical Lung Cancer|2019Cited by 10
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)Benjamin Levy, Jonathan W. Riess, Fabrice Barlési et al.|Lung Cancer|2022Cited by 7